2023
DOI: 10.32471/exp-oncology.2312-8852.vol-43-no-1.15938
|View full text |Cite
|
Sign up to set email alerts
|

ROS production by circulating phagocytes and Guerin carcinoma resistance to cisplatin

Abstract: Background: Tumor drug resistance remains a primary cause of unsuccessful cancer therapy. The search for biological markers of the sensitivity/resistance of malignant neoplasms to drug therapy is an urgent and important task, the solution of which will increase the effectiveness of anticancer chemotherapy. Aim: To study the relationship between the functional activity (parameters of the phagocytosis and reactive oxygen species (ROS) production) of neutrophils and monocytes in the peripheral blood of rats with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…•− , hypochlorous acid or NO [107]. With these limitations, H 2 DCF has been successfully applied to studies of oxidative burst in phagocytes [110,111] and to assess oxidative processes in different cell models [112][113][114][115][116].…”
Section: O 2 Probesmentioning
confidence: 99%
“…•− , hypochlorous acid or NO [107]. With these limitations, H 2 DCF has been successfully applied to studies of oxidative burst in phagocytes [110,111] and to assess oxidative processes in different cell models [112][113][114][115][116].…”
Section: O 2 Probesmentioning
confidence: 99%
“…The role of neutrophil ROS production and its effects on tumor cell growth or death are likely to depend on the particular neutrophil phenotype predominating within the tumor microenvironment and the local ROS levels that they release. Thus, several studies have implicated neutrophil-mediated ROS production in promoting tumor colonization [ 29 ] and chemotherapy resistance [ 30 ]. However, it is clear that by using appropriate factors it is possible to enhance and promote beneficial neutrophil recruitment and activation such as IL-17 [ 31 ], bacterial-based products [ 32 , 33 ] or poly I:C double-stranded RNA [ 34 ], and these neutrophils provide potent anti-tumor immunity involving greater ROS production as detailed in the following sections.…”
Section: Introductionmentioning
confidence: 99%